1 Market Overview

1.1 Product Overview and Scope of Hospital Injectable Drugs

1.2 Classification of Hospital Injectable Drugs by Type

1.2.1 Overview: Global Hospital Injectable Drugs Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Hospital Injectable Drugs Revenue Market Share by Type in 2021

1.2.3 Generic Sterile Injectables

1.2.4 Sterile Intravenous (IV) Solutions

1.3 Global Hospital Injectable Drugs Market by Application

1.3.1 Overview: Global Hospital Injectable Drugs Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Oncology

1.3.3 Anesthesia

1.3.4 Anti-Infectives

1.3.5 Parenteral Nutrition

1.3.6 Cardiovascular Diseases

1.4 Global Hospital Injectable Drugs Market Size & Forecast

1.5 Global Hospital Injectable Drugs Market Size and Forecast by Region

1.5.1 Global Hospital Injectable Drugs Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Hospital Injectable Drugs Market Size by Region, (2017-2022)

1.5.3 North America Hospital Injectable Drugs Market Size and Prospect (2017-2028)

1.5.4 Europe Hospital Injectable Drugs Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Hospital Injectable Drugs Market Size and Prospect (2017-2028)

1.5.6 South America Hospital Injectable Drugs Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Hospital Injectable Drugs Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Hospital Injectable Drugs Market Drivers

1.6.2 Hospital Injectable Drugs Market Restraints

1.6.3 Hospital Injectable Drugs Trends Analysis

2 Company Profiles

2.1 Hospira (Pfizer Inc.)

2.1.1 Hospira (Pfizer Inc.) Details

2.1.2 Hospira (Pfizer Inc.) Major Business

2.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Product and Solutions

2.1.4 Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Hospira (Pfizer Inc.) Recent Developments and Future Plans

2.2 Baxter

2.2.1 Baxter Details

2.2.2 Baxter Major Business

2.2.3 Baxter Hospital Injectable Drugs Product and Solutions

2.2.4 Baxter Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Baxter Recent Developments and Future Plans

2.3 Fresenius Kabi

2.3.1 Fresenius Kabi Details

2.3.2 Fresenius Kabi Major Business

2.3.3 Fresenius Kabi Hospital Injectable Drugs Product and Solutions

2.3.4 Fresenius Kabi Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Fresenius Kabi Recent Developments and Future Plans

2.4 Sandoz (Novartis)

2.4.1 Sandoz (Novartis) Details

2.4.2 Sandoz (Novartis) Major Business

2.4.3 Sandoz (Novartis) Hospital Injectable Drugs Product and Solutions

2.4.4 Sandoz (Novartis) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Sandoz (Novartis) Recent Developments and Future Plans

2.5 Hikma Pharmaceuticals PLC

2.5.1 Hikma Pharmaceuticals PLC Details

2.5.2 Hikma Pharmaceuticals PLC Major Business

2.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product and Solutions

2.5.4 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Hikma Pharmaceuticals PLC Recent Developments and Future Plans

2.6 Dr. Reddy’s Laboratories Ltd

2.6.1 Dr. Reddy’s Laboratories Ltd Details

2.6.2 Dr. Reddy’s Laboratories Ltd Major Business

2.6.3 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product and Solutions

2.6.4 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans

2.7 Grifols

2.7.1 Grifols Details

2.7.2 Grifols Major Business

2.7.3 Grifols Hospital Injectable Drugs Product and Solutions

2.7.4 Grifols Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Grifols Recent Developments and Future Plans

2.8 Nichi-Iko Group (Sagent)

2.8.1 Nichi-Iko Group (Sagent) Details

2.8.2 Nichi-Iko Group (Sagent) Major Business

2.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product and Solutions

2.8.4 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Nichi-Iko Group (Sagent) Recent Developments and Future Plans

2.9 Teva Pharmaceutical

2.9.1 Teva Pharmaceutical Details

2.9.2 Teva Pharmaceutical Major Business

2.9.3 Teva Pharmaceutical Hospital Injectable Drugs Product and Solutions

2.9.4 Teva Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Teva Pharmaceutical Recent Developments and Future Plans

2.10 Otsuka

2.10.1 Otsuka Details

2.10.2 Otsuka Major Business

2.10.3 Otsuka Hospital Injectable Drugs Product and Solutions

2.10.4 Otsuka Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Otsuka Recent Developments and Future Plans

2.11 B.Braun

2.11.1 B.Braun Details

2.11.2 B.Braun Major Business

2.11.3 B.Braun Hospital Injectable Drugs Product and Solutions

2.11.4 B.Braun Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 B.Braun Recent Developments and Future Plans

2.12 JW Life Science

2.12.1 JW Life Science Details

2.12.2 JW Life Science Major Business

2.12.3 JW Life Science Hospital Injectable Drugs Product and Solutions

2.12.4 JW Life Science Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 JW Life Science Recent Developments and Future Plans

2.13 Auromedics

2.13.1 Auromedics Details

2.13.2 Auromedics Major Business

2.13.3 Auromedics Hospital Injectable Drugs Product and Solutions

2.13.4 Auromedics Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Auromedics Recent Developments and Future Plans

2.14 Sanofi

2.14.1 Sanofi Details

2.14.2 Sanofi Major Business

2.14.3 Sanofi Hospital Injectable Drugs Product and Solutions

2.14.4 Sanofi Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Sanofi Recent Developments and Future Plans

2.15 Gland Pharma

2.15.1 Gland Pharma Details

2.15.2 Gland Pharma Major Business

2.15.3 Gland Pharma Hospital Injectable Drugs Product and Solutions

2.15.4 Gland Pharma Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Gland Pharma Recent Developments and Future Plans

2.16 Endo International PLC

2.16.1 Endo International PLC Details

2.16.2 Endo International PLC Major Business

2.16.3 Endo International PLC Hospital Injectable Drugs Product and Solutions

2.16.4 Endo International PLC Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Endo International PLC Recent Developments and Future Plans

2.17 Sichuan Kelun Pharmaceutical

2.17.1 Sichuan Kelun Pharmaceutical Details

2.17.2 Sichuan Kelun Pharmaceutical Major Business

2.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product and Solutions

2.17.4 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Sichuan Kelun Pharmaceutical Recent Developments and Future Plans

2.18 Cisen Pharmaceutical

2.18.1 Cisen Pharmaceutical Details

2.18.2 Cisen Pharmaceutical Major Business

2.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Product and Solutions

2.18.4 Cisen Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Cisen Pharmaceutical Recent Developments and Future Plans

2.19 Shijiazhuang No. 4 Pharmaceutical

2.19.1 Shijiazhuang No. 4 Pharmaceutical Details

2.19.2 Shijiazhuang No. 4 Pharmaceutical Major Business

2.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product and Solutions

2.19.4 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 Shijiazhuang No. 4 Pharmaceutical Recent Developments and Future Plans

2.20 Shandong Hualu Pharmaceutical

2.20.1 Shandong Hualu Pharmaceutical Details

2.20.2 Shandong Hualu Pharmaceutical Major Business

2.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product and Solutions

2.20.4 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20.5 Shandong Hualu Pharmaceutical Recent Developments and Future Plans

2.21 CR Double-Crane

2.21.1 CR Double-Crane Details

2.21.2 CR Double-Crane Major Business

2.21.3 CR Double-Crane Hospital Injectable Drugs Product and Solutions

2.21.4 CR Double-Crane Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.21.5 CR Double-Crane Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Hospital Injectable Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Hospital Injectable Drugs Players Market Share in 2021

3.2.2 Top 10 Hospital Injectable Drugs Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Hospital Injectable Drugs Players Head Office, Products and Services Provided

3.4 Hospital Injectable Drugs Mergers & Acquisitions

3.5 Hospital Injectable Drugs New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Hospital Injectable Drugs Revenue and Market Share by Type (2017-2022)

4.2 Global Hospital Injectable Drugs Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Hospital Injectable Drugs Revenue Market Share by Application (2017-2022)

5.2 Global Hospital Injectable Drugs Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Hospital Injectable Drugs Revenue by Type (2017-2028)

6.2 North America Hospital Injectable Drugs Revenue by Application (2017-2028)

6.3 North America Hospital Injectable Drugs Market Size by Country

6.3.1 North America Hospital Injectable Drugs Revenue by Country (2017-2028)

6.3.2 United States Hospital Injectable Drugs Market Size and Forecast (2017-2028)

6.3.3 Canada Hospital Injectable Drugs Market Size and Forecast (2017-2028)

6.3.4 Mexico Hospital Injectable Drugs Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Hospital Injectable Drugs Revenue by Type (2017-2028)

7.2 Europe Hospital Injectable Drugs Revenue by Application (2017-2028)

7.3 Europe Hospital Injectable Drugs Market Size by Country

7.3.1 Europe Hospital Injectable Drugs Revenue by Country (2017-2028)

7.3.2 Germany Hospital Injectable Drugs Market Size and Forecast (2017-2028)

7.3.3 France Hospital Injectable Drugs Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Hospital Injectable Drugs Market Size and Forecast (2017-2028)

7.3.5 Russia Hospital Injectable Drugs Market Size and Forecast (2017-2028)

7.3.6 Italy Hospital Injectable Drugs Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Hospital Injectable Drugs Revenue by Type (2017-2028)

8.2 Asia-Pacific Hospital Injectable Drugs Revenue by Application (2017-2028)

8.3 Asia-Pacific Hospital Injectable Drugs Market Size by Region

8.3.1 Asia-Pacific Hospital Injectable Drugs Revenue by Region (2017-2028)

8.3.2 China Hospital Injectable Drugs Market Size and Forecast (2017-2028)

8.3.3 Japan Hospital Injectable Drugs Market Size and Forecast (2017-2028)

8.3.4 South Korea Hospital Injectable Drugs Market Size and Forecast (2017-2028)

8.3.5 India Hospital Injectable Drugs Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Hospital Injectable Drugs Market Size and Forecast (2017-2028)

8.3.7 Australia Hospital Injectable Drugs Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Hospital Injectable Drugs Revenue by Type (2017-2028)

9.2 South America Hospital Injectable Drugs Revenue by Application (2017-2028)

9.3 South America Hospital Injectable Drugs Market Size by Country

9.3.1 South America Hospital Injectable Drugs Revenue by Country (2017-2028)

9.3.2 Brazil Hospital Injectable Drugs Market Size and Forecast (2017-2028)

9.3.3 Argentina Hospital Injectable Drugs Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Hospital Injectable Drugs Revenue by Type (2017-2028)

10.2 Middle East & Africa Hospital Injectable Drugs Revenue by Application (2017-2028)

10.3 Middle East & Africa Hospital Injectable Drugs Market Size by Country

10.3.1 Middle East & Africa Hospital Injectable Drugs Revenue by Country (2017-2028)

10.3.2 Turkey Hospital Injectable Drugs Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Hospital Injectable Drugs Market Size and Forecast (2017-2028)

10.3.4 UAE Hospital Injectable Drugs Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Hospital Injectable Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Hospital Injectable Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Hospital Injectable Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Hospital Injectable Drugs Revenue (USD Million) by Region (2017-2022)

Table 5. Global Hospital Injectable Drugs Revenue Market Share by Region (2023-2028)

Table 6. Hospira (Pfizer Inc.) Corporate Information, Head Office, and Major Competitors

Table 7. Hospira (Pfizer Inc.) Major Business

Table 8. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product and Solutions

Table 9. Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Baxter Corporate Information, Head Office, and Major Competitors

Table 11. Baxter Major Business

Table 12. Baxter Hospital Injectable Drugs Product and Solutions

Table 13. Baxter Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Fresenius Kabi Corporate Information, Head Office, and Major Competitors

Table 15. Fresenius Kabi Major Business

Table 16. Fresenius Kabi Hospital Injectable Drugs Product and Solutions

Table 17. Fresenius Kabi Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Sandoz (Novartis) Corporate Information, Head Office, and Major Competitors

Table 19. Sandoz (Novartis) Major Business

Table 20. Sandoz (Novartis) Hospital Injectable Drugs Product and Solutions

Table 21. Sandoz (Novartis) Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Hikma Pharmaceuticals PLC Corporate Information, Head Office, and Major Competitors

Table 23. Hikma Pharmaceuticals PLC Major Business

Table 24. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product and Solutions

Table 25. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Dr. Reddy’s Laboratories Ltd Corporate Information, Head Office, and Major Competitors

Table 27. Dr. Reddy’s Laboratories Ltd Major Business

Table 28. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product and Solutions

Table 29. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Grifols Corporate Information, Head Office, and Major Competitors

Table 31. Grifols Major Business

Table 32. Grifols Hospital Injectable Drugs Product and Solutions

Table 33. Grifols Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Nichi-Iko Group (Sagent) Corporate Information, Head Office, and Major Competitors

Table 35. Nichi-Iko Group (Sagent) Major Business

Table 36. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product and Solutions

Table 37. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 39. Teva Pharmaceutical Major Business

Table 40. Teva Pharmaceutical Hospital Injectable Drugs Product and Solutions

Table 41. Teva Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Otsuka Corporate Information, Head Office, and Major Competitors

Table 43. Otsuka Major Business

Table 44. Otsuka Hospital Injectable Drugs Product and Solutions

Table 45. Otsuka Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. B.Braun Corporate Information, Head Office, and Major Competitors

Table 47. B.Braun Major Business

Table 48. B.Braun Hospital Injectable Drugs Product and Solutions

Table 49. B.Braun Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. JW Life Science Corporate Information, Head Office, and Major Competitors

Table 51. JW Life Science Major Business

Table 52. JW Life Science Hospital Injectable Drugs Product and Solutions

Table 53. JW Life Science Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Auromedics Corporate Information, Head Office, and Major Competitors

Table 55. Auromedics Major Business

Table 56. Auromedics Hospital Injectable Drugs Product and Solutions

Table 57. Auromedics Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Sanofi Corporate Information, Head Office, and Major Competitors

Table 59. Sanofi Major Business

Table 60. Sanofi Hospital Injectable Drugs Product and Solutions

Table 61. Sanofi Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Gland Pharma Corporate Information, Head Office, and Major Competitors

Table 63. Gland Pharma Major Business

Table 64. Gland Pharma Hospital Injectable Drugs Product and Solutions

Table 65. Gland Pharma Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Endo International PLC Corporate Information, Head Office, and Major Competitors

Table 67. Endo International PLC Major Business

Table 68. Endo International PLC Hospital Injectable Drugs Product and Solutions

Table 69. Endo International PLC Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Sichuan Kelun Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 71. Sichuan Kelun Pharmaceutical Major Business

Table 72. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product and Solutions

Table 73. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Cisen Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 75. Cisen Pharmaceutical Major Business

Table 76. Cisen Pharmaceutical Hospital Injectable Drugs Product and Solutions

Table 77. Cisen Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Shijiazhuang No. 4 Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 79. Shijiazhuang No. 4 Pharmaceutical Major Business

Table 80. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product and Solutions

Table 81. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Shandong Hualu Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 83. Shandong Hualu Pharmaceutical Major Business

Table 84. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product and Solutions

Table 85. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 86. CR Double-Crane Corporate Information, Head Office, and Major Competitors

Table 87. CR Double-Crane Major Business

Table 88. CR Double-Crane Hospital Injectable Drugs Product and Solutions

Table 89. CR Double-Crane Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 90. Global Hospital Injectable Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 91. Global Hospital Injectable Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 92. Breakdown of Hospital Injectable Drugs by Company Type (Tier 1, Tier 2 and Tier 3)

Table 93. Hospital Injectable Drugs Players Head Office, Products and Services Provided

Table 94. Hospital Injectable Drugs Mergers & Acquisitions in the Past Five Years

Table 95. Hospital Injectable Drugs New Entrants and Expansion Plans

Table 96. Global Hospital Injectable Drugs Revenue (USD Million) by Type (2017-2022)

Table 97. Global Hospital Injectable Drugs Revenue Share by Type (2017-2022)

Table 98. Global Hospital Injectable Drugs Revenue Forecast by Type (2023-2028)

Table 99. Global Hospital Injectable Drugs Revenue by Application (2017-2022)

Table 100. Global Hospital Injectable Drugs Revenue Forecast by Application (2023-2028)

Table 101. North America Hospital Injectable Drugs Revenue by Type (2017-2022) & (USD Million)

Table 102. North America Hospital Injectable Drugs Revenue by Type (2023-2028) & (USD Million)

Table 103. North America Hospital Injectable Drugs Revenue by Application (2017-2022) & (USD Million)

Table 104. North America Hospital Injectable Drugs Revenue by Application (2023-2028) & (USD Million)

Table 105. North America Hospital Injectable Drugs Revenue by Country (2017-2022) & (USD Million)

Table 106. North America Hospital Injectable Drugs Revenue by Country (2023-2028) & (USD Million)

Table 107. Europe Hospital Injectable Drugs Revenue by Type (2017-2022) & (USD Million)

Table 108. Europe Hospital Injectable Drugs Revenue by Type (2023-2028) & (USD Million)

Table 109. Europe Hospital Injectable Drugs Revenue by Application (2017-2022) & (USD Million)

Table 110. Europe Hospital Injectable Drugs Revenue by Application (2023-2028) & (USD Million)

Table 111. Europe Hospital Injectable Drugs Revenue by Country (2017-2022) & (USD Million)

Table 112. Europe Hospital Injectable Drugs Revenue by Country (2023-2028) & (USD Million)

Table 113. Asia-Pacific Hospital Injectable Drugs Revenue by Type (2017-2022) & (USD Million)

Table 114. Asia-Pacific Hospital Injectable Drugs Revenue by Type (2023-2028) & (USD Million)

Table 115. Asia-Pacific Hospital Injectable Drugs Revenue by Application (2017-2022) & (USD Million)

Table 116. Asia-Pacific Hospital Injectable Drugs Revenue by Application (2023-2028) & (USD Million)

Table 117. Asia-Pacific Hospital Injectable Drugs Revenue by Region (2017-2022) & (USD Million)

Table 118. Asia-Pacific Hospital Injectable Drugs Revenue by Region (2023-2028) & (USD Million)

Table 119. South America Hospital Injectable Drugs Revenue by Type (2017-2022) & (USD Million)

Table 120. South America Hospital Injectable Drugs Revenue by Type (2023-2028) & (USD Million)

Table 121. South America Hospital Injectable Drugs Revenue by Application (2017-2022) & (USD Million)

Table 122. South America Hospital Injectable Drugs Revenue by Application (2023-2028) & (USD Million)

Table 123. South America Hospital Injectable Drugs Revenue by Country (2017-2022) & (USD Million)

Table 124. South America Hospital Injectable Drugs Revenue by Country (2023-2028) & (USD Million)

Table 125. Middle East & Africa Hospital Injectable Drugs Revenue by Type (2017-2022) & (USD Million)

Table 126. Middle East & Africa Hospital Injectable Drugs Revenue by Type (2023-2028) & (USD Million)

Table 127. Middle East & Africa Hospital Injectable Drugs Revenue by Application (2017-2022) & (USD Million)

Table 128. Middle East & Africa Hospital Injectable Drugs Revenue by Application (2023-2028) & (USD Million)

Table 129. Middle East & Africa Hospital Injectable Drugs Revenue by Country (2017-2022) & (USD Million)

Table 130. Middle East & Africa Hospital Injectable Drugs Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Hospital Injectable Drugs Picture

Figure 2. Global Hospital Injectable Drugs Revenue Market Share by Type in 2021

Figure 3. Generic Sterile Injectables

Figure 4. Sterile Intravenous (IV) Solutions

Figure 5. Hospital Injectable Drugs Revenue Market Share by Application in 2021

Figure 6. Oncology Picture

Figure 7. Anesthesia Picture

Figure 8. Anti-Infectives Picture

Figure 9. Parenteral Nutrition Picture

Figure 10. Cardiovascular Diseases Picture

Figure 11. Global Hospital Injectable Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Hospital Injectable Drugs Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Hospital Injectable Drugs Revenue Market Share by Region (2017-2028)

Figure 14. Global Hospital Injectable Drugs Revenue Market Share by Region in 2021

Figure 15. North America Hospital Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Hospital Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Hospital Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Hospital Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Hospital Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Hospital Injectable Drugs Market Drivers

Figure 21. Hospital Injectable Drugs Market Restraints

Figure 22. Hospital Injectable Drugs Market Trends

Figure 23. Hospira (Pfizer Inc.) Recent Developments and Future Plans

Figure 24. Baxter Recent Developments and Future Plans

Figure 25. Fresenius Kabi Recent Developments and Future Plans

Figure 26. Sandoz (Novartis) Recent Developments and Future Plans

Figure 27. Hikma Pharmaceuticals PLC Recent Developments and Future Plans

Figure 28. Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans

Figure 29. Grifols Recent Developments and Future Plans

Figure 30. Nichi-Iko Group (Sagent) Recent Developments and Future Plans

Figure 31. Teva Pharmaceutical Recent Developments and Future Plans

Figure 32. Otsuka Recent Developments and Future Plans

Figure 33. B.Braun Recent Developments and Future Plans

Figure 34. JW Life Science Recent Developments and Future Plans

Figure 35. Auromedics Recent Developments and Future Plans

Figure 36. Sanofi Recent Developments and Future Plans

Figure 37. Gland Pharma Recent Developments and Future Plans

Figure 38. Endo International PLC Recent Developments and Future Plans

Figure 39. Sichuan Kelun Pharmaceutical Recent Developments and Future Plans

Figure 40. Cisen Pharmaceutical Recent Developments and Future Plans

Figure 41. Shijiazhuang No. 4 Pharmaceutical Recent Developments and Future Plans

Figure 42. Shandong Hualu Pharmaceutical Recent Developments and Future Plans

Figure 43. CR Double-Crane Recent Developments and Future Plans

Figure 44. Global Hospital Injectable Drugs Revenue Share by Players in 2021

Figure 45. Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 46. Global Top 3 Players Hospital Injectable Drugs Revenue Market Share in 2021

Figure 47. Global Top 10 Players Hospital Injectable Drugs Revenue Market Share in 2021

Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 49. Global Hospital Injectable Drugs Revenue Share by Type in 2021

Figure 50. Global Hospital Injectable Drugs Market Share Forecast by Type (2023-2028)

Figure 51. Global Hospital Injectable Drugs Revenue Share by Application in 2021

Figure 52. Global Hospital Injectable Drugs Market Share Forecast by Application (2023-2028)

Figure 53. North America Hospital Injectable Drugs Sales Market Share by Type (2017-2028)

Figure 54. North America Hospital Injectable Drugs Sales Market Share by Application (2017-2028)

Figure 55. North America Hospital Injectable Drugs Revenue Market Share by Country (2017-2028)

Figure 56. United States Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Canada Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Mexico Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Europe Hospital Injectable Drugs Sales Market Share by Type (2017-2028)

Figure 60. Europe Hospital Injectable Drugs Sales Market Share by Application (2017-2028)

Figure 61. Europe Hospital Injectable Drugs Revenue Market Share by Country (2017-2028)

Figure 62. Germany Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. France Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. United Kingdom Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Russia Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Italy Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Asia-Pacific Hospital Injectable Drugs Sales Market Share by Type (2017-2028)

Figure 68. Asia-Pacific Hospital Injectable Drugs Sales Market Share by Application (2017-2028)

Figure 69. Asia-Pacific Hospital Injectable Drugs Revenue Market Share by Region (2017-2028)

Figure 70. China Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Japan Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. South Korea Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. India Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Southeast Asia Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Australia Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. South America Hospital Injectable Drugs Sales Market Share by Type (2017-2028)

Figure 77. South America Hospital Injectable Drugs Sales Market Share by Application (2017-2028)

Figure 78. South America Hospital Injectable Drugs Revenue Market Share by Country (2017-2028)

Figure 79. Brazil Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Argentina Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Middle East and Africa Hospital Injectable Drugs Sales Market Share by Type (2017-2028)

Figure 82. Middle East and Africa Hospital Injectable Drugs Sales Market Share by Application (2017-2028)

Figure 83. Middle East and Africa Hospital Injectable Drugs Revenue Market Share by Country (2017-2028)

Figure 84. Turkey Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 85. Saudi Arabia Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 86. UAE Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 87. Methodology

Figure 88. Research Process and Data Source